Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACTR3BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTLL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928728 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928865 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC19A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTIF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC23B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on